Breast Cancer During Pregnancy

• Conditions: Pregnancy; Breast Cancer

• Registration Number: NCT02102282
• Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Brief Summary

Patients are managed clinically according to ad hoc standards and scientific knowledge by a multidisciplinary team. Clinical decisions are made after a patient physician discussion. Blood and tissue samples are collected. Diagnostic, obstetric management surgical treatment, systemic treatment, perinatal results and follow up data are collected.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10
• Status Verified: 2014-03
• Study First Submitted: 2014-03-29
• Study First Submitted QC: 2014-04-01
• Last Update Submitted: 2014-04-01
• Study First Posted: 2014-04-02
• Last Update Posted: 2014-04-02
• Primary Completion: 2022-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• Patients with breast cancer diagnosed during pregnancy

Exclusion Criteria

• Patients who refuse informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Perinatal results	Delivery	Gestational age, weight, Apgar, blood tests

Secondary Outcome Measures

Name	Time	Method
Maternal outcome	5 year and 10 year	Over all survival, disease free survival

Trial Locations

Locations (1)

Hospital Vall d'Hebron; 🇪🇸 Barcelona, Spain